Abstract: A heat processing apparatus includes a reaction vessel, a heating unit in the reaction vessel to heat the processing region, a temperature detector that detects temperature in the processing region, and a control part to control the heating unit by PID control. The control part has a rule table, and a performance unit that obtains temperature profiles and calculates differences between actually measured temperatures and target values. It refers to the rule table change the PID constants. The control part also updates relationships between PID constants and predicted temperature change amounts.

Abstract: To provide a method for treating diabetes which has an excellent hypoglycemic action and causes minimal adverse drug reactions, there is provided a medicine comprising a DPP-IV inhibitor and an insulin sensitizer in combination.

Abstract: Method for treatment of a human patient having hypoadiponectinemia. 5-[4-(6-methoxy-1-methyl-1H-benzimidazol-2-ylmethoxy)benzyl]thiazolidine-2,4-dione or a pharmacologically salt thereof is administered in an amount effective to raise the level of adiponectine in said patient.

Abstract: A heat processing apparatus comprises: a reaction vessel; a heating unit disposed in the reaction vessel and configured to heat the processing region; a temperature detection part configured to detect a temperature of the processing region; and a control part configured to control the heating unit by a PID control.

Abstract: The present invention relates to a pharmaceutical composition comprising an insulin sensitizer and a diuretic which can prevent or treat side effects such as edema, cardiac enlargement, body fluid retension or hydrothorax caused by administration of an insulin sensitizer.

Abstract: A method for treating a disease, in which side effects (for example, edema) are suppressed while maintaining appropriate pharmaceutical effects. The method involves a cycle of administration of the insulin sensitizer wherein the dosage thereof is reduced or withdrawn alternated with administration of an effective dose.

Abstract: The present invention relates to a pharmaceutical composition comprising an insulin sensitizer and a diuretic which can prevent or treat side effects such as edema, cardiac enlargement, body fluid retension or hydrothorax caused by administration of an insulin sensitizer.

Abstract: The present invention relates to a pharmaceutical composition comprising an insulin sensitizer and a diuretic which can prevent or treat side effects such as edema, cardiac enlargement, body fluid retension or hydrothorax caused by administration of an insulin sensitizer.

Abstract: A process for preparing a water-in-oil emulsion of a water-soluble polymer is disclosed, comprising polymerizing at least one water-soluble vinyl monomer in a water-in-oil emulsion, wherein the dissolved oxygen concentration of the emulsion under polymerization is about 100 ppb or less. The desired emulsion can be obtained without being accompanied by the formation of agglomerates.

Abstract: The present invention provides a composition for recovery of petroleum and gas, which comprises (a) a copolymer having a molecular weight of 100,000 or more, composed of 30-75 mole % of N-vinylpyrrolidone unit, 5-70 mole % of (meth)acrylamide unit and 0-20 mole % of (meth)acrylic acid unit or a salt thereof, (b) a water-soluble aldehyde, (c) a phenol compound, and (d) water. This composition can form a gel in a required gelling time even at high temperatures and even in the presence of bivalent metal ions and accordingly can be used for efficient recovery of petroleum and gas.

Abstract: There is disclosed a process for producing an acrylamide polymer which comprises polymerizing acrylamide monomer alone or a monomer mixture composed of 50 mole % or more of acrylamide monomer and a monomer capable of copolymerizing with acrylamide monomer in the presence of an azo series polymerization initiator and 0.1% by weight or more of 2-mercaptobenzothiazole or a salt thereof based on the weight of the monomer in an aqueous medium having a pH of 6 or higher at a temperature range of 5 to 100.degree. C., and then drying the resulting material.

Abstract: A water-in-oil emulsion of a cationic polymer suitable for inversion, comprising a continuous phase comprising a hydrophobic liquid, a discontinuous phase comprising a water-soluble cationic polymer, and a surface active agent system for inventing the emulsion in water, the system comprising a mixture of at least one alkyl phosphate represented by formula (I) or (II) and at least one other surface active agent compatible with the at least one alkyl phosphate: ##STR1## wherein R.sub.1 represents a saturated or unsaturated hydrocarbon group having from 8 to 18 carbon atoms; X and Y, which may be the same or different, each represents a hydrogen atom, an alkali metal, an ammonium group, or an alkanolamino group; and n1 represents 0 or an integer of from 1 to 4; ##STR2## wherein R.sub.2 and R.sub.

Abstract: A method of stabilizing an aqueous solution of xanthan gum is disclosed, comprising incorporating at least one stabilizing agent selected from thiol derivatives of heterocyclic compounds in an aqueous solution of xanthan gum.

Abstract: A stabilized fracturing fluid and a method of stabilizing a fracturing fluid containing at least one of guar gum and its derivatives is disclosed, wherein at least one stabilizing compound selected from the thiol derivatives of heterocyclic compounds is added to the fracturing fluid. This method of stabilization prevents degradation of the fracturing fluid, i.e., reduction in its rheological properties at high temperatures and permits smooth practice of the fracturing operation.

Abstract: A process for producing a modified hydroxyethyl cellulose comprising the steps of:allowing hydroxyethyl cellulose to be swollen in a solvent; andmixing the hydroxyethyl cellulose swollen in the solvent, with a 2-mercapto benzimidazole compound having the formula (I): ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, and R.sup.4 independently represent hydrogen, methyl, or ethyl, and X is hydrogen, an alkali metal, an alkaline earth metal, or ammonium.

Abstract: A stabilized fracturing fluid and a method of stabilizing a fracturing fluid containing at least one of guar gum and a derivative thereof is disclosed, comprising adding at least one stabilizing compound selected from 2-mercaptobenzimidazole and 2-mercaptobenzothiazole compounds to the fracturing fluid. This stabilization prevents degradation of the fracturing fluid, i.e., reduction in its rheological properties at high temperatures and permits smoothly carrying out the fracturing operation.

Abstract: A completion and workover fluid which comprises an aqueous liquid medium containing hydroxyethyl cellulose, an inorganic salt selected from the group consisting of calcium chloride, calcium bromide and zinc bromide, and a component selected from the group consisting of the following components:(1) thiol derivatives of heterocyclic compounds;(2) thioamide derivatives;(3) at least one compound selected from the group consisting of thiuram disulfide compounds, thiuram monosulfide compounds and dithiocarbamate compounds;(4) benzothiazole; and(5) a copper compound and an iodine compound in combination.

Abstract: A completion and workover fluid is described, containing a soluble salt, a hydroxyethyl cellulose and at least one compound selected from 2-mercaptobenzimidazole compounds, 2-mercaptobenzothiazole compounds, 2-mercaptothiazoline and 2-thioimidazolidone.

Abstract: A method of stabilizing an aqueous solution of xanthan gum is described, comprising incorporating at least one stabilizing agent selected from the group consisting of 2-mercaptobenzimidazole and derivatives thereof in an aqueous solution of xanthan gum.

Abstract: A drilling fluid is described, consisting essentially of sodium carboxymethyl cellulose, bentonite, water, and at least one compound selected from 2-mercaptobenzimidazole compounds, 2-mercaptobenzothiazole compounds, 2-mercaptothiazoline and 2-thioimidazolidone.